Adze1.C / Adze Biotech - LARVOL DELTA

A Study to Evaluate Adze1.C in Participants With Metastatic Melanoma (clinicaltrials.gov) - P1 | N=30 | Recruiting | Sponsor: Adze Biotechnology Australia Pty Ltd | Trial completion date: Jul 2027 ➔ Oct 2028 | Trial primary completion date: Nov 2026 ➔ Oct 2027

Trial completion date • Trial primary completion date • Melanoma • Oncology • Solid Tumor

A Study to Evaluate Adze1.C in Participants With Metastatic Melanoma (clinicaltrials.gov) - P1 | N=30 | Recruiting | Sponsor: Adze Biotechnology Australia Pty Ltd | Not yet recruiting ➔ Recruiting

Enrollment open • Melanoma • Oncology • Solid Tumor

A Study to Evaluate Adze1.C in Participants With Metastatic Melanoma (clinicaltrials.gov) - P1 | N=30 | Not yet recruiting | Sponsor: Adze Biotechnology Australia Pty Ltd

New P1 trial • Melanoma • Oncology • Solid Tumor